piperazine has been researched along with Obesity in 3 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kotańska, M | 1 |
Kulig, K | 1 |
Marcinkowska, M | 1 |
Bednarski, M | 1 |
Malawska, K | 1 |
Zaręba, P | 1 |
Singh, K | 1 |
Sona, C | 1 |
Ojha, V | 1 |
Singh, M | 1 |
Mishra, A | 1 |
Kumar, A | 1 |
Siddiqi, MI | 1 |
Tripathi, RP | 1 |
Yadav, PN | 1 |
Berger, R | 1 |
Zhu, C | 1 |
Hansen, AR | 1 |
Harper, B | 1 |
Chen, Z | 1 |
Holt, TG | 1 |
Hubert, J | 1 |
Lee, SJ | 1 |
Pan, J | 1 |
Qian, S | 1 |
Reitman, ML | 1 |
Strack, AM | 1 |
Weingarth, DT | 1 |
Wolff, M | 1 |
Macneil, DJ | 1 |
Weber, AE | 1 |
Edmondson, SD | 1 |
3 other studies available for piperazine and Obesity
Article | Year |
---|---|
Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Blood Pressure; Body Temperature; Body Weight; Die | 2018 |
Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT
Topics: Allosteric Regulation; Animals; Eating; Heterocyclic Compounds; Molecular Docking Simulation; Obesit | 2019 |
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
Topics: Animals; Anti-Obesity Agents; Benzodiazepines; Chemokines, CC; Humans; Indoles; Methylamines; Mice; | 2008 |